PureCycle Technologies (PCT) is back in focus after announcing SnapPack Square EVO, a tamper evident food packaging platform that uses 20% of its PureFive recycled polypropylene resin in every container.
See our latest analysis for PureCycle Technologies.
Despite the SnapPack Square EVO launch and record PureFive production in the June quarter, PureCycle Technologies’ 1 year total shareholder return has fallen 43.14%, while the 30 day share price return has risen 19.35%. This suggests recent momentum after a tougher stretch.
If this kind of packaging-focused story has your attention, it can be useful to widen your search to other opportunities in recycling, materials and infrastructure and check out 21 top founder-led companies
For PureCycle Technologies, a 19.35% move in 30 days after a 43.14% decline over the past year raises a simple question: Is the price starting to catch up with the underlying progress, or are expectations just resetting?
Most Popular Narrative: 31.9% Undervalued
The most followed narrative currently pegs PureCycle Technologies at a fair value of $10.60 compared with the last close of $7.22, which implies a sizeable valuation gap based on its assumptions.
Growing interest from large consumer brands and quick service restaurant chains in circular packaging solutions for coffee lids, cups and snack packaging is creating a pipeline of high volume applications that management links to 40 million to 50 million pounds of potential annual demand. This directly targets future revenue scale.
Readers may want to examine the revenue ramp, margin shift and future earnings multiple this narrative is leaning on. The core thesis hangs on aggressive scaling and a premium profit profile that is usually reserved for more mature sectors. It may also be useful to consider which assumptions need to hold for that $10.60 figure to be supported.
Result: Fair Value of $10.60 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, PureCycle Technologies still carries execution and funding risks, including potential delays at Ironton and Denver, as well as the possibility of future capital raises diluting existing shareholders.
Find out about the key risks to this PureCycle Technologies narrative.
Another View On PureCycle Technologies Valuation
The analyst fair value for PureCycle Technologies leans heavily on future earnings, yet today the stock trades on a P/B of about 93.5x versus roughly 2.2x for peers and 1.7x for the wider US Chemicals industry. That is a large gap that may indicate meaningful valuation risk if expectations soften.
Numbers like these can be useful as a reality check on any upside story. If the business does not progress as quickly as models assume, how much room is there for the share price to adjust back toward a lower P/B level?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
The mixed messages around PureCycle Technologies, with both risks and potential rewards in play, mean the story is still wide open. Take a closer look at the underlying data, challenge the assumptions on both sides, and weigh the 1 key reward and 2 important warning signs
Looking for more investment ideas beyond PureCycle Technologies?
If PureCycle Technologies has sharpened your focus on where capital goes next, do not stop here. Broader idea sourcing can sharpen your edge and reduce blind spots.
- Target potential mispricing by scanning companies that score well on quality and valuation through the 53 high quality undervalued stocks.
- Build resilience into your watchlist by focusing on companies with strong finances using the solid balance sheet and fundamentals stocks screener (50 results).
- Spot early opportunities before they attract wider attention by checking the screener containing 19 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com